A Phase I Study of PS-341 (NSC 681239), Carboplatin, and Etoposide in Patients With Advanced Solid Tumors Refractory to Standard Therapy.
Phase of Trial: Phase I
Latest Information Update: 06 Feb 2013
At a glance
- Drugs Bortezomib (Primary) ; Carboplatin; Etoposide
- Indications Solid tumours
- Focus Adverse reactions
- 18 Aug 2005 New trial record.